nach oben

Journal of Natural Medicines

Erschienen in:

01.04.2013 | Original Paper

Protective effect of plaunotol against doxorubicin-induced renal cell death

verfasst von: Chatchai Chaotham, Wanchai De-Eknamkul, Pithi Chanvorachote

Erschienen in: Journal of Natural Medicines | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In searching for a safe and effective compound to be used as a chemoprotective agent to prevent toxicity of the anthracyclin doxorubicin to renal cells, the present study demonstrated that plaunotol, a purified acyclic diterpene from Croton stellatopilosus Ohba, showed potential protection against doxorubicin-induced cell death in human proximal tubule cells. Treatment of renal cells with doxorubicin resulted in a significant decrease in viability of the cells, and we next proved that such toxicity was mainly due to apoptotic cell death. Pretreatment of the cells with plaunotol for at least 9 h prior to doxorubicin exposure improved the cells’ survival. Plaunotol was shown to up-regulate the anti-apoptotic myeloid cell leukemia-1 (Mcl-1) level whereas it had no effect on the Bcl-2 level. The reduction in Mcl-1 after doxorubicin treatment was shown to be closely associated with the toxic action of the drug, and the increase in Mcl-1 induced by plaunotol pretreatment was able to prevent cell death induced by doxorubicin. Furthermore, the protective effect of plaunotol was evaluated in human lung and melanoma cells. Results indicated that plaunotol had no significantly protective effect in human lung carcinoma cells, whereas it sensitized melanoma cells to drug-induced cell death.

Lown JW (1993) Anthracycline and anthraquinone anticancer agents: current status and recent developments. Pharmacol Ther 60:185–214PubMedCrossRef

Mansour MA, El-Kashef HA, Al-Shabanah OA (1999) Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res 39:233–237PubMedCrossRef

Saad SY, Najjar TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211–218. doi:10.1006/phrs.2000.0769 PubMedCrossRef

Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900–905PubMedCrossRef

Burke JF Jr, Laucius JF, Brodovsky HS, Soriano RZ (1977) Doxorubicin hydrochloride-associated renal failure. Arch Intern Med 137:385–388PubMedCrossRef

Cheng CY, Sue YM, Chen CH, Hou CC, Chan P, Chu YL, Chen TH, Hsu YH (2006) Tetramethylpyrazine attenuates adriamycin-induced apoptotic injury in rat renal tubular cells NRK-52E. Planta Med 72:888–893. doi:10.1055/s-2006-946695 PubMedCrossRef

Ueda N, Shah SV (2000) Tubular cell damage in acute renal failure-apoptosis, necrosis, or both. Nephrol Dial Transplant 15:318–323PubMedCrossRef

Zhang J, Clark JR Jr, Herman EH, Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931–1943PubMedCrossRef

Boonsanit D, Kanchanapangka S, Buranakarl C (2006) l-Carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats. Nephrology (Carlton) 11:313–320. doi:10.1111/J.1440-1797.2006.00592.X CrossRef

10.

Boutabet K, Kebsa W, Alyane M, Lahouel M (2010) Polyphenolic fraction of Algerian propolis protects rat kidney against acute oxidative stress induced by doxorubicin. Indian J Nephrol 21:101–106

11.

Chen CH, Lin H, Hsu YH, Sue YM, Cheng TH, Chan P, Chen TH (2006) The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol 529:8–15. doi:10.1016/J.EJPHAR.2005.10.057 PubMedCrossRef

12.

Lebrecht D, Setzer B, Rohrbach R, Walker UA (2004) Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant 19:329–336. doi:10.1093/ndt/gfg564 PubMedCrossRef

13.

Akgul C (2009) Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 66:1326–1336. doi:10.1007/s00018-008-8637-6 PubMedCrossRef

14.

Michels J, Johnson PWM, Packham G (2005) Molecules in focus––Mcl-1. Int J Biochem Cell Biol 37:267–271. doi:10.1016/J.BIOCEL.2004.04.007 PubMedCrossRef

15.

Thomas LW, Lam C, Edwards SW (2010) Mcl-1; the molecular regulation of protein function. FEBS Lett 584:2981–2989. doi:10.1016/j.febslet.2010.05.061 PubMedCrossRef

16.

Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H (1998) Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res 58:5565–5569PubMed

17.

Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B, Pawel BR, Hogarty MD (2009) Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer Biol Ther 8:1587–1595PubMedCrossRef

18.

Lopez-Royuela N, Perez-Galan P, Galan-Malo P, Yuste VJ, Anel A, Susin SA, Naval J, Marzo I (2010) Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells. Biochem Pharmacol 79:1746–1758. doi:10.1016/J.BCP.2010.02.010 PubMedCrossRef

19.

Wirth T, Kuhnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L, Kubicka S (2005) Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1. Cancer Res 65:7393–7402. doi:10.1158/0008-5472.CAN-04-3664 PubMedCrossRef

20.

Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309–1319PubMed

21.

Paduch R, Kandefer-Szerszen M, Trytek M, Fiedurek J (2007) Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 55:315–327. doi:10.1007/s00005-007-0039-1 CrossRef

22.

Higuchi K, Watanabe T, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T (2007) Are gastroprotective drugs useful for gastric ulcer healing: re-evaluation using current ICH E9 guidelines. Inflammopharmacology 15:18–21. doi:10.1007/s10787-006-0300-y PubMedCrossRef

23.

Yamada J, Kawai K, Tsuno NH, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M, Okaji Y, Takahashi K, Nagawa H (2007) Plaunotol induces apoptosis of gastric cancer cells. Planta Med 73:1068–1073. doi:10.1055/s-2007-981578 PubMedCrossRef

24.

Yoshikawa N, Yamada J, Tsuno NH, Okaji Y, Kawai K, Tsuchiya T, Yoneyama S, Tanaka J, Shuno Y, Nishikawa T, Nagawa H, Oshima N, Takahashi K (2009) Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer. J Surg Res 153:246–253. doi:10.1016/J.JSS.2008.04.021 PubMedCrossRef

25.

Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK, Rahmani M, Wei J, Hedvat M, Dent P, Dmitriev IP, Curiel DT, Grant S, Wu B, Stebbins JL, Pellecchia M, Reed JC, Sarkar D, Fisher PB (2011) Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc Natl Acad Sci USA 108:8785–8790. doi:10.1073/pnas.1100769108 PubMedCrossRef

26.

Dash R, Richards JE, Su ZZ, Bhutia SK, Azab B, Rahmani M, Dasmahapatra G, Yacoub A, Dent P, Dmitriev IP, Curiel DT, Grant S, Pellecchia M, Reed JC, Sarkar D, Fisher PB (2010) Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine. Cancer Res 70:5034–5045. doi:10.1158/0008-5472.CAN-10-0563 PubMedCrossRef

27.

Chen W, Bai L, Wang X, Xu S, Belinsky SA, Lin Y (2010) Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 77:416–423. doi:10.1124/mol.109.061226 PubMedCrossRef

28.

Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F (2008) Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol Cancer Res 6:42–52. doi:10.1158/1541-7786.MCR-07-0080 PubMedCrossRef

29.

Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, Chinnaiyan AM, Markovitz DM, Soengas MS (2009) Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res 69:6405–6413. doi:10.1158/0008-5472.CAN-09-1063 PubMedCrossRef

30.

Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, Lin Y (2008) Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol Cancer Ther 7:1156–1163. doi:10.1158/1535-7163.MCT-07-2183 PubMedCrossRef

31.

Murakami K, Okajima K, Harada N, Isobe H, Liu W, Johno M, Okabe H (1999) Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Aliment Pharmacol Ther 13:521–530PubMedCrossRef

32.

Ohta Y, Kamiya Y, Imai Y, Arisawa T, Nakano H (2005) Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacology 74:182–192. doi:10.1159/000085388 PubMedCrossRef

33.

Burlacu A (2003) Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7:249–257. doi:10.1111/j.1582-4934.2003.tb00225.x PubMedCrossRef

34.

Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T, Green DR (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 105:20327–20332. doi:10.1073/pnas.0808036105 PubMedCrossRef

35.

Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351:41–58. doi:10.1007/s11010-010-0709-x PubMedCrossRef

36.

Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59. doi:10.1038/NRM2308 PubMedCrossRef

37.

Liu L, Yang C, Herzog C, Seth R, Kaushal GP (2010) Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol 79:137–146. doi:10.1016/j.bcp.2009.08.015 PubMedCrossRef

38.

Ou YC, Yang CR, Cheng CL, Li JR, Raung SL, Hung YY, Chen CJ (2009) Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation. Biochem Biophys Res Commun 380:531–536. doi:10.1016/j.bbrc.2009.01.094 PubMedCrossRef

39.

Yang C, Kaushal V, Shah SV, Kaushal GP (2007) Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. Am J Physiol Renal Physiol 292:F1710–F1717. doi:10.1152/AJPRENAL.00505.2006 PubMedCrossRef

40.

Gong X, Celsi G, Carlsson K, Norgren S, Chen M (2010) N-Acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling. Am J Nephrol 31:178–188. doi:10.1159/000268161

41.

Lin MT, Lee RC, Yang PC, Ho FM, Kuo ML (2001) Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 276:48997–49002. doi:10.1074/JBC.M107829200 PubMedCrossRef

42.

Fu H, Yabe Y, Asahi K, Hayashi Y, Murata H, Eguchi H, Tsujii M, Tsuji S, Kawano S (2005) (2E,6Z,10E)-7-Hydroxymethyl-3,11,15-trimethyl-2,6,10,14-hexadecatetraen-1-ol (Plaunotol) increases cyclooxygenase-2 expression via nuclear factor kappaB and cyclic AMP response element in rat gastric epithelial cells. Eur J Pharmacol 524:38–43. doi:10.1016/J.EJPHAR.2005.09.044 PubMedCrossRef

Titel: Protective effect of plaunotol against doxorubicin-induced renal cell death
verfasst von: Chatchai Chaotham
Wanchai De-Eknamkul
Pithi Chanvorachote
Publikationsdatum: 01.04.2013
Verlag: Springer Japan
Erschienen in: Journal of Natural Medicines / Ausgabe 2/2013
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-012-0683-6

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

A new diterpenoid from the leaves of Clerodendron trichotomum

Two new sulfated oleanan saponins from Achyranthes root

Fargesin, a component of Flos Magnoliae, stimulates glucose uptake in L6 myotubes

Regular ingestion of cinnamomi cortex pulveratus offers gastroprotective activity in mice

New cycloartane glycosides from the aerial part of Thalictrum fortunei

Comparative studies of saponins in 1–3-year-old main roots, fibrous roots, and rhizomes of Panax notoginseng, and identification of different parts and growth-year samples